Streetinsider.com's Hot Lunchtime Reads 10/24: (ADRO) (AMTD) (TWTR) (INO)

October 24, 2016 12:15 PM EDT

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

The following is a list of notable articles to help get you through the lunch hour:
  • Twitter's (TWTR) 'Underweight' Rating Reiterated at Morgan Stanley -> Read this!

  • TD Ameritrade (AMTD) Ratings Placed on Review for Upgrade by Moody's -> Read this!

  • Roth Capital Affirms Bioblast Pharma (ORPN) at 'Buy'; Sees Trehalose PK Data as 'Meaningful' -> Read this!

  • Under Armour (UA) puts active onto Q3 and outlook -> Read this!

  • Inovio Pharmaceuticals (INO) PT Lowered to $11 at Stifel -> Read this!

  • Seaport Global Securities Upgrades Tutor Perini Corporation (TPC) to Buy -> Read this!

  • Roth Capital Trims PT on Aduro Biotech (ADRO) to $20 Amid FDA Partial Hold on LADD Trials -> Read this!



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Special Reports

Related Entities

Stifel, Morgan Stanley, Roth Capital, Twitter

Add Your Comment